Ribbon Acquisition Corp Closes $50M IPO on NASDAQ
Biotechnology
Initial Public Offering / IPO
Merger Vote:
Sep 10, 2026
Industry:
BLANK CHECKS
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Ribbon Acquisition Corp Completes $50 Million Initial Public Offering
New York, New York, Jan. 16, 2025 -- Ribbon Acquisition Corp (NASDAQ: RIBBU) announced the successful closing of its initial public offering (IPO), raising $50 million. The offering consisted of 5,000,000 units, each priced at $10.00.
... Read on — Members only
About DRC Medicine Ltd.
Founded in 2007, DRC is an innovative healthcare and biotechnology company headquartered in Japan, focused on the research, development, and commercialization of advanced medical technologies that address significant global health challenges. The Company is best known for its proprietary Hydro Silver Titanium® technology, initially applied in consumer hygiene products such as masks and towels, and now being advanced to obtain medical device certification as among the world’s first therapeutic masks for seasonal allergic rhinitis . In addition to medical devices, the Company is developing a pipeline of In Vitro Diagnostic (“IVD”) kits for infectious diseases and allergen detection, combining its world-only cell-free protein synthesis technology leveraging AI powered Apps and is in final negotiation in acquiring an innovative ATP-enhancing drug for Parkinson’s disease.
More RIBB News
Biotechnology
Initial Public Offering / IPO
Daily overview of upcoming SPAC and IPO events – from initial announcement to definitive agreement and public listing.
Discover last week’s SPAC and IPO highlights, key trends, and market updates. Stay informed with SpacStar.